Marker Therapeutics Inc
NASDAQ:MRKR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Marker Therapeutics Inc
NASDAQ:MRKR
|
US |
|
Latent View Analytics Ltd
NSE:LATENTVIEW
|
IN |
|
Autozone Inc
NYSE:AZO
|
US |
|
Celyad Oncology SA
F:1C0
|
BE |
|
Cimpress PLC
NASDAQ:CMPR
|
IE |
Wall St Price Targets
MRKR Price Targets Summary
Marker Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
MRKR is 8.02 USD with a low forecast of 5.66 USD and a high forecast of 10.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MRKR's stock price target?
Price Target
8.02
USD
According to Wall Street analysts, the average 1-year price target for
MRKR is 8.02 USD with a low forecast of 5.66 USD and a high forecast of 10.5 USD.
What is the Revenue forecast for Marker Therapeutics Inc?
Projected CAGR
61%
The compound annual growth rate for Revenue over the next 6 years is 61%.